首页 › 基金 › BAKER BROS. ADVISORS LP › VRDN

BAKER BROS. ADVISORS LP 对 VRDN 的持仓历史

VIRIDIAN THERAPEUTICS INC · 医疗保健

BAKER BROS. ADVISORS LP 在 Q2 2026 的 13F 申报中披露持有 VRDN(VIRIDIAN THERAPEUTICS INC)2,383,025 股,市值约 US$43.8M,约占其申报组合的 0.23%,在其申报持仓中市值排名第 40 位。 BAKER BROS. ADVISORS LP 最近 5 个申报季度中有 5 个季度披露了 VRDN 持仓,最早可追溯至 Q2 2025。

最新持仓 (Q2 2026)2.38M 股
申报持仓市值$43.78M
组合权重0.23%
首次申报Q2 2025
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

BAKER BROS. ADVISORS LP 对 VRDN 的持仓演变

BAKER BROS. ADVISORS LP 于 Q2 2025 首次披露 VRDN 持仓:1,744,406 股(约 US$24.4M)。 该持仓在 Q4 2025 达到峰值 1,971,678 股,市值约 US$61.4M。 在 5 次申报中,BAKER BROS. ADVISORS LP 2 次增持、0 次减持、2 次保持不变。 最近一期申报(Q2 2026)显示持股 2,383,025 股、市值约 US$43.8M,环比增持 411,347 股。。

逐季持仓明细

季度股数金额变化
Q2 2025 1.74M $24.39M 新进
Q3 2025 1.74M $37.64M 持有
Q4 2025 1.97M $61.36M 增持
Q1 2026 1.97M $38.57M 持有
Q2 2026 2.38M $43.78M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VRDN 与 13F 数据

VRDN(VIRIDIAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 VRDN,申报仓位最大的包括:Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VRDN 的基金

查看 VRDN 的全部基金持有人 →

常见问题

How long has BAKER BROS. ADVISORS LP held VRDN?

BAKER BROS. ADVISORS LP has disclosed VRDN holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is BAKER BROS. ADVISORS LP's current position in VRDN?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 2.38M shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $43.78M, representing 0.23% of its reported portfolio and ranking #40.

Has BAKER BROS. ADVISORS LP been buying or selling VRDN?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP increased its position in VRDN. The position peaked in Q4 2025 at 1.97M shares.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.